(Q33698391)

28 July 2017

Treatment of Gambling Disorders (English)

1 reference

28 July 2017

2

Marc N Potenza

1 reference

28 July 2017

Sarah W Yip

1

1 reference

28 July 2017

1 June 2014

1 reference

Current treatment options in psychiatry

28 July 2017

1 reference

28 July 2017

1

1 reference

28 July 2017

2

1 reference

28 July 2017

189-203

1 reference

https://scigraph.springernature.com/pub.10.1007/s40501-014-0014-5

28 July 2017

0 references

cites work

A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Neurobiology of gambling behaviors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

An overview of and rationale for changes proposed for pathological gambling in DSM-5

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Psychological therapies for pathological and problem gambling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

An empirical evaluation of proposed changes for gambling diagnosis in the DSM-5.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Health/functioning characteristics, gambling behaviors, and gambling-related motivations in adolescents stratified by gambling problem severity: findings from a high school survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Impulse control disorders in Parkinson's disease: clinical characteristics and implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Glutamatergic medications for the treatment of drug and behavioral addictions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

New medications for drug addiction hiding in glutamatergic neuroplasticity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Correlates of at-risk/problem internet gambling in adolescents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Adolescent gambling: research and clinical implications.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Gambling problem severity and psychiatric disorders among Hispanic and white adults: findings from a nationally representative sample

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Pharmacological treatment of adolescent pathological gambling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Motivational interviewing versus cognitive behavioral group therapy in the treatment of problem and pathological gambling: a randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

The glutamate homeostasis hypothesis of addiction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

A systematic review and meta-analysis of cognitive-behavioural interventions to reduce problem gambling: hedging our bets?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

The relationship between recreational gambling and substance abuse/dependence: data from a nationally representative sample

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Predicting response to opiate antagonists and placebo in the treatment of pathological gambling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Gambling, health and age: data from the National Epidemiologic Survey on Alcohol and Related Conditions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Gender differences among recreational gamblers: association with the frequency of alcohol use.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Olanzapine: a critical review of recent literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Sertraline treatment of pathological gambling: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

21 June 2018

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Commentary on Petry et al. (2013): Actus Reus--why it matters to pathological gambling treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Pathological Gambling: Neuropsychopharmacology and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

A double-blind, placebo-controlled trial of topiramate for pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Evidence for glutamatergic neurotransmission in cognitive control in an auditory attention task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

A randomized trial of deep-brain stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40501-014-0014-5

A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

Lithium and valproate treatment of pathological gambling: a randomized single-blind study.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

A pilot placebo-controlled study of fluvoxamine for pathological gambling.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041397

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling

30 October 2018

1 reference

12 December 2020

Comorbidity of impulse control disorders in pathological gamblers

1 reference

12 December 2020

Pathological gambling in Parkinson disease is reduced by amantadine

1 reference

12 December 2020

Short-term single-blind fluvoxamine treatment of pathological gambling

1 reference

12 December 2020

Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation

1 reference

12 December 2020

10.1007/S40501-014-0014-5

Identifiers

DOI

1 reference

PubMed ID

24904757

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference

PubMed ID

24904757